• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Key mutations may protect against coronary artery disease

byJon LiuandXu Gao
November 13, 2014
in Cardiology, Chronic Disease, Genetics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Genetic mutations that led to the inactivation NPC1L1, a lipid transporter protein, were linked to lower low-density lipoprotein (LDL) and total cholesterol levels.

Evidence Rating Level: 2 (Good)

Study Rundown: Ezetimibe is a lipid-lowering agent thought to block lipid absorption by inhibiting the Niemann-Pick C1-like 1 gene (NPC1L1), which codes for a protein that transports cholesterol from the gut lumen into enterocytes. Previous genome-wide studies have demonstrated an association between low-density lipoprotein (LDL) levels and genetic sequence variation in NPC1L1. Elevated LDL is a well-known risk factor for coronary artery disease.

This genetic study combined data collected internationally from prior case-control and cohort studies. Initially, a total of 15 common “inactivating mutations” were identified in the exon (protein-coding) regions of NPC1L1. Patients who were carriers of one of the 15 inactivating mutations were noted to have statistically significant reductions in both LDL and total cholesterol (as compared to non-carriers). Among patients with established coronary heart disease, carrier frequency for one of the 15 inactivating mutations was 0.04% versus 0.09% in those without coronary heart disease.

As only inactivating mutations were examined, the lipid-lowering effect of NPC1L1 mutations may have been understated as other types of mutations were not included in this study (e.g., frame-shift, splice-site). Furthermore, other phenotypic consequences of NPC1L1 mutations were not studied therefore the lipid lowering benefits may be offset by other uncharacterized changes. This study once again emphasizes the importance of genetic predisposition when considering a patient’s risk of coronary heart disease. Future studies are likely to focus on the clinical impact of earlier NPC1L1 blockade as a form of primary prophylaxis against coronary heart disease.

Click to read the study, published today in NEJM

RELATED REPORTS

Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans

Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients

Mirum: Ctexli reduces cholesterol metabolite build-up in patients with cerebrotendinous xanthomatosis

Relevant Reading: Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport

In-Depth [genetic analysis study]: This study included data from 16 prior case-control and cohort studies. After sequencing NPC1L1 from approximately 21,000 patients, a total of 15 inactivating mutations were identified in 34 patients (“carriers”). When compared to non-carriers, carriers had lower levels of total cholesterol (0.34 mmol/L, p=0.03) and LDL (0.31 mmol/L, p=0.04). No statistical difference was noted in triglyceride levels or high-density lipoprotein (non-carriers vs. carriers). Carrier frequency was lower (0.04%) in the group with coronary heart disease versus the group without coronary heart disease (0.09%), leading to a risk reduction of 53% among carriers (p=0.008).

More from this author: Rituximab superior to azathioprine in autoimmune vasculitis, Ultrasound as effective as CT at identifying high-risk kidney stones, reduces radiation exposure, Lower blood transfusion threshold in septic shock safe at 90-days, Influenza vaccination in pregnancy protects both mother and infant, Sirolimus may prevent graft failure in patients with renal transplantation for antiphospholipid syndrome

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: cholesterolCoronary artery diseaseLDL
Previous Post

Morbid obesity increases risk for cervical cancer death

Next Post

Smokers’ support for plain tobacco packaging linked to desire to quit

RelatedReports

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study
Cardiology

Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans

June 26, 2025
Parental nonmedical prescription opioid use linked to adolescent use
Cardiology

Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients

June 10, 2025
CT texture analysis may predict liver insufficiency after hepatectomy
Pharma

Mirum: Ctexli reduces cholesterol metabolite build-up in patients with cerebrotendinous xanthomatosis

April 15, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Patients with coronary artery disease have sustained elevation in blood pressure following exercise

February 28, 2025
Next Post
Number of lives saved due to tobacco control continues to rise

Smokers' support for plain tobacco packaging linked to desire to quit

Vitamin deficiency may persist after Omega-loop gastric bypass

Vitamin deficiency may persist after Omega-loop gastric bypass

Chronic marijuana use linked to structural differences in the brain

Chronic marijuana use linked to structural differences in the brain

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.